Th17 down-regulation by metformin has also been demonstrated in a hepatocellular carcinoma model associated with a decrease in IL-22 secretion, as well as a transient increase in Treg cells in a leukemia solid tumor model [14, 46]. This evidence concerns the gene IL22 and hepatocellular carcinoma.